Alyeska Investment Group, L.P. - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q1 2021$468,000
-48.5%
265,820
-42.9%
0.01%
-53.8%
Q4 2020$908,000
-60.8%
465,820
-52.0%
0.01%
-62.9%
Q3 2020$2,317,000
+170.4%
969,547
+231.4%
0.04%
+169.2%
Q2 2020$857,000
-62.2%
292,546
-50.0%
0.01%
-55.2%
Q2 2019$2,265,000
+1642.3%
585,265
+3540.4%
0.03%
+2800.0%
Q4 2015$130,000
-72.2%
16,077
-71.3%
0.00%
-80.0%
Q3 2015$468,000
-50.3%
55,943
-45.0%
0.01%0.0%
Q2 2015$942,000
+92.2%
101,646
+103.3%
0.01%
-28.6%
Q1 2015$490,00050,0000.01%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Perceptive Advisors 33,169,604$53,072,0000.34%
Clearline Capital LP 922,517$1,476,0000.22%
GSA CAPITAL PARTNERS LLP 860,911$1,377,0000.16%
Prosight Management, LP 115,100$184,0000.12%
Banco BTG Pactual S.A. 92,500$148,0000.10%
Meridian Wealth Management, LLC 164,000$262,0000.03%
Shay Capital LLC 159,614$255,0000.03%
Signature Wealth Management Partners, LLC 10,500$17,0000.02%
XTX Topco Ltd 24,881$40,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 227,469$364,0000.01%
View complete list of ADMA BIOLOGICS INC shareholders